182 related articles for article (PubMed ID: 1292337)
1. Mobilization of an intracellular glycoprotein (Mac-1) on monocytes and granulocytes during hemodialysis.
Thylén P; Lundahl J; Fernvik E; Hed J; Svenson SB; Jacobson SH
Am J Nephrol; 1992; 12(6):393-400. PubMed ID: 1292337
[TBL] [Abstract][Full Text] [Related]
2. Cell surface receptor modulation on monocytes and granulocytes during clinical and experimental hemodialysis.
Thylén P; Fernvik E; Lundahl J; Hed J; Jacobson SH
Am J Nephrol; 1995; 15(5):392-400. PubMed ID: 7503138
[TBL] [Abstract][Full Text] [Related]
3. Modulation of CD11b/CD18 on monocytes and granulocytes following hemodialysis membrane interaction in vitro.
Thylén P; Fernvik E; Lundahl J; Hed J; Jacobson SH
Int J Artif Organs; 1996 Mar; 19(3):156-63. PubMed ID: 8675359
[TBL] [Abstract][Full Text] [Related]
4. CD31 expression on leukocytes is downregulated in vivo during hemodialysis.
Kawabata K; Nakai S; Miwa M; Sugiura T; Otsuka Y; Shinzato T; Hiki N; Tomimatsu I; Ushida Y; Hosono F; Maeda K
Nephron; 2001 Oct; 89(2):153-60. PubMed ID: 11549897
[TBL] [Abstract][Full Text] [Related]
5. Dialysis granulocytopenia is preceded by an increased surface expression of the adhesion-promoting glucoprotein Mac-1.
Lundahl J; Hed J; Jacobson SH
Nephron; 1992; 61(2):163-9. PubMed ID: 1630540
[TBL] [Abstract][Full Text] [Related]
6. Adhesion molecules and leukocyte common antigen on monocytes and granulocytes during hemodialysis.
Tielemans CL; Delville JP; Husson CP; Madhoun P; Lambrechts AM; Goldman M; Vanherweghem JL
Clin Nephrol; 1993 Mar; 39(3):158-65. PubMed ID: 8096446
[TBL] [Abstract][Full Text] [Related]
7. Modulation of granulocyte LAM-1 and MAC-1 during dialysis--a prospective, randomized controlled trial.
Himmelfarb J; Zaoui P; Hakim R
Kidney Int; 1992 Feb; 41(2):388-95. PubMed ID: 1372668
[TBL] [Abstract][Full Text] [Related]
8. Vitamin E-bonded cellulose membrane and hemodialysis bioincompatibility: absence of an acute benefit on expression of leukocyte surface molecules.
Dhondt A; Vanholder R; Glorieux G; Waterloos MA; De Smet R; Lesaffer G; Lameire N
Am J Kidney Dis; 2000 Dec; 36(6):1140-6. PubMed ID: 11096038
[TBL] [Abstract][Full Text] [Related]
9. The changes of Mac-1 and L-selectin expression on granulocytes and soluble L-selectin level during hemodialysis.
Kawabata K; Nagake Y; Shikata K; Makino H; Ota Z
Nephron; 1996; 73(4):573-9. PubMed ID: 8856254
[TBL] [Abstract][Full Text] [Related]
10. Monocyte and granulocyte CD11b/CD18, CD62L expression and sICAM-1 concentration in the interdialytic period.
Thylén P; Fernvik E; Lundahl J; Lins LE; Jacobson SH
Nephron; 1996; 74(2):275-82. PubMed ID: 8893141
[TBL] [Abstract][Full Text] [Related]
11. Leukocyte CD14 and CD45 expression during hemodialysis: polysulfone versus cuprophane.
Dhondt AW; Vanholder RC; Waterloos MA; Glorieux GL; Ringoir SM
Nephron; 1996; 74(2):342-8. PubMed ID: 8893153
[TBL] [Abstract][Full Text] [Related]
12. Effect of uremia and hemodialysis on soluble L-selectin and leukocyte surface CD11b and L-selectin.
Dou L; Brunet P; Dignat-George F; Sampol J; Berland Y
Am J Kidney Dis; 1998 Jan; 31(1):67-73. PubMed ID: 9428454
[TBL] [Abstract][Full Text] [Related]
13. Biocompatibility of hemodialysis membranes: interrelations between plasma complement and cytokine levels.
Varela MP; Kimmel PL; Phillips TM; Mishkin GJ; Lew SQ; Bosch JP
Blood Purif; 2001; 19(4):370-9. PubMed ID: 11574733
[TBL] [Abstract][Full Text] [Related]
14. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
Hoenich NA; Woffindin C; Cox PJ; Goldfinch M; Roberts SJ
Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo biocompatibility of substituted cellulose and synthetic membranes.
Mandolfo S; Tetta C; David S; Gervasio R; Ognibene D; Wratten ML; Tessore E; Imbasciati E
Int J Artif Organs; 1997 Nov; 20(11):603-9. PubMed ID: 9464869
[TBL] [Abstract][Full Text] [Related]
16. On complement net generation in fast hemodialysis: are high blood flow rates bioincompatible?
Skroeder NR; Kjellstrand P; Holmquist B; Kjellstrand CM; Jacobson SH
Am J Kidney Dis; 1995 Jun; 25(6):896-903. PubMed ID: 7771486
[TBL] [Abstract][Full Text] [Related]
17. Effect of regional citrate anticoagulation on leukopenia, complement activation, and expression of leukocyte surface molecules during hemodialysis with unmodified cellulose membranes.
Dhondt A; Vanholder R; Tielemans C; Glorieux G; Waterloos MA; De Smet R; Lameire N
Nephron; 2000 Aug; 85(4):334-42. PubMed ID: 10940744
[TBL] [Abstract][Full Text] [Related]
18. Soluble complement receptor 1 inhibits both complement and granulocyte activation during ex vivo hemodialysis.
Himmelfarb J; McMonagle E; Holbrook D; Toth C
J Lab Clin Med; 1995 Oct; 126(4):392-400. PubMed ID: 7561449
[TBL] [Abstract][Full Text] [Related]
19. Effects of aprotinin on complement and granulocyte activation during ex vivo hemodialysis.
Himmelfarb J; Holbrook D; McMonagle E
Am J Kidney Dis; 1994 Dec; 24(6):901-6. PubMed ID: 7527183
[TBL] [Abstract][Full Text] [Related]
20. Expression of beta-2-integrins and L-selectin by leukocytes and changes in acute-phase reactants in total hip replacement surgery.
Høgevold HE; Lyberg T; Kähler H; Reikerås O
Eur Surg Res; 1996; 28(3):190-200. PubMed ID: 8738529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
